BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18467512)

  • 1. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms.
    Togo S; Holz O; Liu X; Sugiura H; Kamio K; Wang X; Kawasaki S; Ahn Y; Fredriksson K; Skold CM; Mueller KC; Branscheid D; Welker L; Watz H; Magnussen H; Rennard SI
    Am J Respir Crit Care Med; 2008 Aug; 178(3):248-60. PubMed ID: 18467512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.
    Ikari J; Nelson AJ; Obaid J; Giron-Martinez A; Ikari K; Makino F; Iwasawa S; Gunji Y; Farid M; Wang X; Basma H; Demeo D; Feghali-Bostwick C; Holz O; Rabe K; Liu X; Rennard SI
    PLoS One; 2017; 12(9):e0184039. PubMed ID: 28880936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
    Dagouassat M; Gagliolo JM; Chrusciel S; Bourin MC; Duprez C; Caramelle P; Boyer L; Hue S; Stern JB; Validire P; Longrois D; Norel X; Dubois-Randé JL; Le Gouvello S; Adnot S; Boczkowski J
    Am J Respir Crit Care Med; 2013 Apr; 187(7):703-14. PubMed ID: 23328527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered fibroblast proteoglycan production in COPD.
    Hallgren O; Nihlberg K; Dahlbäck M; Bjermer L; Eriksson LT; Erjefält JS; Löfdahl CG; Westergren-Thorsson G
    Respir Res; 2010 May; 11(1):55. PubMed ID: 20459817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced miR-146a increases prostaglandin E₂in chronic obstructive pulmonary disease fibroblasts.
    Sato T; Liu X; Nelson A; Nakanishi M; Kanaji N; Wang X; Kim M; Li Y; Sun J; Michalski J; Patil A; Basma H; Holz O; Magnussen H; Rennard SI
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1020-9. PubMed ID: 20522791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β₁ is increased in chronic obstructive pulmonary disease.
    Baarsma HA; Spanjer AI; Haitsma G; Engelbertink LH; Meurs H; Jonker MR; Timens W; Postma DS; Kerstjens HA; Gosens R
    PLoS One; 2011; 6(9):e25450. PubMed ID: 21980461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF synthesis is induced by prostacyclin and TGF-β in distal lung fibroblasts from COPD patients and control subjects: Implications for pulmonary vascular remodelling.
    Westergren-Thorsson G; Bagher M; Andersson-Sjöland A; Thiman L; Löfdahl CG; Hallgren O; Bjermer L; Larsson-Callerfelt AK
    Respirology; 2018 Jan; 23(1):68-75. PubMed ID: 28834088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
    Togo S; Liu X; Wang X; Sugiura H; Kamio K; Kawasaki S; Kobayashi T; Ertl RF; Ahn Y; Holz O; Magnussen H; Fredriksson K; Skold CM; Rennard SI
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L959-69. PubMed ID: 19304913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.
    Larsson-Callerfelt AK; Hallgren O; Andersson-Sjöland A; Thiman L; Björklund J; Kron J; Nihlberg K; Bjermer L; Löfdahl CG; Westergren-Thorsson G
    Respir Res; 2013 Feb; 14(1):21. PubMed ID: 23406566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels.
    Kobayashi T; Kim H; Liu X; Sugiura H; Kohyama T; Fang Q; Wen FQ; Abe S; Wang X; Atkinson JJ; Shipley JM; Senior RM; Rennard SI
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L1006-15. PubMed ID: 24705725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.
    Michalski J; Kanaji N; Liu X; Nogel S; Wang X; Basma H; Nakanishi M; Sato T; Gunji Y; Fahrid M; Nelson A; Muller KC; Holz O; Magnussen H; Rabe KF; Toews ML; Rennard SI
    Am J Respir Cell Mol Biol; 2012 Dec; 47(6):729-37. PubMed ID: 23043089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
    Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome.
    Hoshika Y; Takahashi F; Togo S; Hashimoto M; Nara T; Kobayashi T; Nurwidya F; Kataoka H; Kurihara M; Kobayashi E; Ebana H; Kikkawa M; Ando K; Nishino K; Hino O; Takahashi K; Seyama K
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27905298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts.
    Liu X; Nelson A; Wang X; Farid M; Gunji Y; Ikari J; Iwasawa S; Basma H; Feghali-Bostwick C; Rennard SI
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):40-50. PubMed ID: 23941558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis.
    Sugiura H; Liu X; Kobayashi T; Togo S; Ertl RF; Kawasaki S; Kamio K; Wang XQ; Mao L; Shen L; Hogaboam CM; Rennard SI
    Am J Respir Cell Mol Biol; 2006 May; 34(5):592-9. PubMed ID: 16399954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblasts that resist cigarette smoke-induced senescence acquire profibrotic phenotypes.
    Kanaji N; Basma H; Nelson A; Farid M; Sato T; Nakanishi M; Wang X; Michalski J; Li Y; Gunji Y; Feghali-Bostwick C; Liu X; Rennard SI
    Am J Physiol Lung Cell Mol Physiol; 2014 Sep; 307(5):L364-73. PubMed ID: 25015975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary fibroblasts from COPD patients show an impaired response of elastin synthesis to TGF-β1.
    Zhang J; Wu L; Feng MX; Sexton P; Bai CX; Qu JM; Merrilees M; Black PN
    Respir Physiol Neurobiol; 2011 Aug; 177(3):236-40. PubMed ID: 21539942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E₂ possesses different potencies in inducing Vascular Endothelial Growth Factor and Interleukin-8 production in COPD human lung fibroblasts.
    Bonanno A; Albano GD; Siena L; Montalbano AM; Riccobono L; Anzalone G; Chiappara G; Gagliardo R; Profita M; Sala A
    Prostaglandins Leukot Essent Fatty Acids; 2016 Mar; 106():11-8. PubMed ID: 26926362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of matrix contraction in chronic venous disease.
    Pappas PJ; Lal BK; Ohara N; Saito S; Zapiach L; Durán WN
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):518-29. PubMed ID: 19560950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
    Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.